Ulocuplumab

Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models.
Read more
€0.00 (tax incl.)
Reference:
HY-P99272
Product Details
HY-P99272

Data sheet

Size
Multiple sizes
Reactivity
CXCR
Application
Cancer-programmed cell death
CAS
1375830-34-4

Menu

Settings